Expression of Erythroid-specific Genes in Acute Megakaryoblastic Leukaemia and Transient Myeloproliferative Disorder in Down's Syndrome
Overview
Affiliations
Acute megakaryoblastic leukaemia (M7) and transient myeloproliferative disorder in Down's syndrome (TMD) are characterized by rapid growth of abnormal blast cells which express megakaryocytic markers. To clarify properties of the blast cells in M7 and TMD cases, we examined erythroid markers expression in blasts from six cases with M7 and seven cases with TMD in this study. Erythroid-specific mRNAs encoding gamma-globin and erythroid delta-aminolevulinate synthase were found to be expressed in blasts from most of these cases, indicating that majorities of the blasts in M7 and TMD cases have erythroid and megakaryocytic phenotypes. We also found that mRNAs encoding GATA-1 and GATA-2 are expressed in all these cases. These results suggest that M7 blasts and TMD blasts correspond to the erythroid/megakaryocytic bipotential progenitor cells.
Kanezaki R, Toki T, Terui K, Sato T, Kobayashi A, Kudo K Sci Rep. 2022; 12(1):20587.
PMID: 36447001 PMC: 9708825. DOI: 10.1038/s41598-022-25046-z.
Raha-Chowdhury R, Raha A, Henderson J, Ghaffari S, Grigorova M, Beresford-Webb J J Clin Med. 2021; 10(13).
PMID: 34209847 PMC: 8268765. DOI: 10.3390/jcm10132909.
MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome.
Shaham L, Vendramini E, Ge Y, Goren Y, Birger Y, Tijssen M Blood. 2014; 125(8):1292-301.
PMID: 25533034 PMC: 4335082. DOI: 10.1182/blood-2014-06-581892.
Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation.
Woo A, Wieland K, Huang H, Akie T, Piers T, Kim J J Clin Invest. 2013; .
PMID: 23863621 PMC: 3726146. DOI: 10.1172/JCI40609.
Myeloid leukemia in Down syndrome.
Khan I, Malinge S, Crispino J Crit Rev Oncog. 2011; 16(1-2):25-36.
PMID: 22150305 PMC: 3243928. DOI: 10.1615/critrevoncog.v16.i1-2.40.